Saturday, May 3, 2008

Biosensing nanodevice to revolutionize health screenings

While the device in question boasts some spectacular future uses, it is all the more remarkable for the technology (or rather biology) behind it. The biosensing capabilities of the nanodevice stem from the utilization of the enzyme F1-adenosine triphosphatase, better known as F1- ATPase, which rotates as other structures bind to DNA and a solution with ATP is added. The rotation causes the emission of a red signal which can be observed via microscope. Scientists hope that this technique might be used to detect the presence of pathogens and other agents rapidly and efficiently for medical and security purposes. While the article is astonishing solely on technical grounds, it offers an important example of the importance of selling science to the public in ways that interest them. If the title of this article had read "Biosensing nanodevice through utilization of F1-ATPase", it would have failed to capture the public's interest. Making the nanotechnology relevant required framing it upon its potential uses.

No comments: